Tumour screening and clinical management

Secondary prevention Method in which previous therapeutic intervention is possible through screening an asymptomatic population to recognize cancer at an earlier stage than it would have been diagnoised in absence of screening.
There are 3 national screening programmes
Bowel cancer screening is seen in people aged 60-74
Breast cancer screening is offered to women, some transgender men and certain non-binary people aged 50-70
Cervical screening is seen in women, some transgender men and some non-binary people aged 25-64
Conference Series extends its welcome to the Global Virtual Summit on Oncology and Radiology during May 11-12, 2023, as a webinar with a theme “Innovatie approaches for treatment of cancer”. RADIOCANCER 2023 Conference will focus on educational research directed toward its impact on clinical outcomes, through oral and poster presentations, educational workshop sessions, and influential plenary presentations. RADIOCANCER 2023 is a perfect platform to find out how cancer and Oncology research innovations helpful to the Medical, Health and human society. Conference will mainly focus on the trending topics during presentations of the two-day event, which reflect current education, research, developments and innovations internationally in the field of cancer, oncology and medical sectors.
Whatsapp number +44 1303 610264